MSLE
Satellos Bioscience Inc. - Common Stock (MSLE)
$05
About Satellos Bioscience Inc. - Common Stock (MSLE)
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.
Details
Daily high
$8.60
Daily low
$8.05
Price at open
$8.46
52 Week High
$13.39
52 Week Low
$5.30
Market cap
180.3M
Dividend yield
-
Volume
24,845
Avg. volume
61,369
P/E ratio
-4.29
Satellos Bioscience Inc. - Common Stock News
Details
Daily high
$8.60
Daily low
$8.05
Price at open
$8.46
52 Week High
$13.39
52 Week Low
$5.30
Market cap
180.3M
Dividend yield
-
Volume
24,845
Avg. volume
61,369
P/E ratio
-4.29